# Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy

> **NCT02926027** · PHASE4 · COMPLETED · sponsor: **Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center** · enrollment: 80 (actual)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DRUG:** Vascepa
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02926027
- **Lead sponsor:** Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-28
- **Primary completion:** 2020-05-15
- **Final completion:** 2020-08-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02926027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02926027, "Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02926027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*